company-logo

Oculis Holding AG, a clinical-stage biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. The company's lead candidate is OCS-01, a topical dexamethasone formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for keratoconjunctivitis sicca, or dry eye disease; and OCS-05, a novel neuroprotective agent for acute optic neuritis and other neuro-ophtha disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company is based in Zug, Switzerland.

Oculis Dividend Announcement

Oculis does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on Oculis dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Oculis Dividend History

Oculis Dividend Yield

Oculis current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Oculis stock? Use our calculator to estimate your expected dividend yield:

Oculis Financial Ratios

P/E ratio-7.16
PEG ratio4.67
P/B ratio5.24
ROE-73.13%
Payout ratio0.00%
Current ratio4.02
Quick ratio4.02
Cash Ratio1.29

Oculis Dividend FAQ

Does Oculis stock pay dividends?
Oculis does not currently pay dividends to its shareholders.
Has Oculis ever paid a dividend?
No, Oculis has no a history of paying dividends to its shareholders. Oculis is not known for its dividend payments.
Why doesn't Oculis pay dividends?
There are several potential reasons why Oculis would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Oculis ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Oculis has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Oculis a dividend aristocrat?
Oculis is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Oculis a dividend king?
Oculis is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Oculis a dividend stock?
No, Oculis is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Oculis stocks?
To buy Oculis you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Oculis stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.